市场调查报告书

配药全球市场:治疗领域,产品,应用,制剂类型,无菌,按分销渠道进行的行业分析,按地区进行的行业分析,区域展望,增长潜力,价格趋势,竞争性市场占有率和未来预测(2020-2026年) )

Compounding Pharmacies Market Size By Therapeutic Area, Product, Application, Compounding Type, Sterility, Distribution Channel, Industry Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020-2026

出版商 Global Market Insights Inc. 商品编码 942665
出版日期 内容资讯 英文 348 Pages
商品交期: 2-3个工作天内
价格
配药全球市场:治疗领域,产品,应用,制剂类型,无菌,按分销渠道进行的行业分析,按地区进行的行业分析,区域展望,增长潜力,价格趋势,竞争性市场占有率和未来预测(2020-2026年) ) Compounding Pharmacies Market Size By Therapeutic Area, Product, Application, Compounding Type, Sterility, Distribution Channel, Industry Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020-2026
出版日期: 2020年06月05日内容资讯: 英文 348 Pages
简介

随著患者对定制药物和可帮助治疗多种疾病的药物的需求不断增长,预计配药药房市场将在未来几年内记录增长。配药药房通常生产定制药品和非上市或非上市药品。这些药房可以给与其他形式的药物,药物剂量,无糖药物等。

按治疗领域,产品,用途,分配类型,无菌性和分配渠道细分了分配药房市场。

根据治疗领域,药房市场分为膳食补充剂,特种药物,皮肤病学应用,疼痛管理,替代激素等。

2019年,膳食补充剂市场价值超过5.8亿美元。膳食补充剂是旨在提供营养的膳食补充剂,包括蛋白质,矿物质,氨基酸,维生素和其他营养物质。这些产品通常以片剂,胶囊或液体的形式服用。

就产品而言,药房市场分为耳,眼,鼻,肠胃外,直肠,局部和口服。鼻产品部门在2019年获得了大约8%的市场份额。鼻腔给药是通过鼻腔注射药物的给药途径。

鼻腔输送有助于解决与药物降解,胃肠道不良事件,吸收延迟,生物利用度降低有关的问题,并避免肝脏中的首度通过代谢。

在应用方面,配药市场分为兽医,老年人,成人和儿童。到分析阶段结束时,老年应用细分市场可能会记录约6.5%的CAGR。陪伴动物数量的急剧增加将推动动物群体的增长。

按药物类型划分的市场分为药物剂量变化(PDA),当前不可用的药物生产(CUPM),药物成分变化(PIA)等。

2019年,CUPM领域的市场价值超过22亿美元。药品短缺的原因有很多,包括质量问题,由于使用减少和制造商利润减少而导致的停药和延误。它还可能影响新药的发布。

关于无菌,药房市场分为非无菌和无菌剂型。在预期的时期内,无菌剂型将以大约6.5%的CAGR增长。随著慢性疾病的发生率增加,对无菌药物的需求预计会增加。

根据分销渠道,配药药房市场分为配药药房,医院药房等。其他细分市场在2019年的市场价值超过8.5亿美元,并有望继续大幅增长。

该报告调查了全球制药市场,并总结了市场概况,细分市场趋势,地区趋势以及进入市场的主要公司的概况。

内容

第1章调查方法

  • 调查方法
  • 市场定义
  • 预测参数
  • 数据源
    • 次要
    • 主要

第2章执行摘要

  • 配药行业概览,2015-2026年
    • 业务趋势
    • 治疗领域的趋势
    • 产品趋势
    • 应用趋势
    • 复合类型趋势
    • 不孕趋势
    • 分销渠道趋势
    • 区域趋势

第3章配药行业的考虑因素

  • 行业细分
  • 2015-2026年行业情势
  • 工业生态系统分析
    • 分销渠道分析
  • 对行业的影响
    • 成长要因
    • 行业陷阱和挑战
  • 增长潜力分析
    • 按治疗领域
    • 按产品
    • 通过申请
    • 按配方类型
    • 无菌
    • 通过分销渠道
  • 法规状态
    • 美国
    • 欧洲
    • 澳大利亚
  • 报销情况
    • 美国
    • 欧洲
    • 澳大利亚
  • 联合用药成本分析
  • 2019年按地区划分的配药店数量
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东/非洲
  • 创新的混合技□□术
    • 基于Web的质量控制系统
    • 数字工具
  • 波特分析
  • PESTEL分析

第4章按治疗领域划分的市场

  • 主要细分趋势
  • 激素补充
    • 区域激素替代市场,2015-2026年,(百万美元)
  • 疼痛管理
    • 区域疼痛管理市场,2015-2026年,(百万美元)
  • 皮肤科医生
    • 按地区分列的皮肤科市场,2015-2026年(百万美元)
  • 特种医学
    • 按地区划分的特种药物市场,2015-2026年(百万美元)
  • 膳食补充剂
    • 按地区分列的营养补充剂市场,2015-2026年(百万美元)
  • 其他
    • 按地区分列的其他市场,2015-2026年,(百万美元)

第5章按产品分配药房市场

  • 主要细分趋势 口语
    • 按地区划分的经口制剂市场,2015-2026年(百万美元)
    • 固体制剂
    • 液体制剂
  • 本地
    • 2015-2026年按地区分列的当地市场,(百万美元)
    • 药膏
    • 乳霜
    • 凝胶
    • 粘贴
    • 其他
  • 直肠
    • 2015-2026年按区域划分的直肠市场(百万美元)
    • 栓剂
    • 灌肠
    • 其他
  • 肠胃外
    • 2015-2026年按地区划分的肠胃外市场(百万美元)
    • 小肠外(SVP)解决方案
    • 大剂量肠胃外(LVP)解决方案
  • 鼻子
    • 区域鼻子市场,2015-2026年(百万美元)
  • 眼科
    • 按区域分列的眼科市场,2015-2026年(百万美元)
  • 耳鼻喉科
    • 2015-2026年各地区的桨叶市场(百万美元)

第6章通过应用分配药房市场

  • 主要细分趋势
  • 儿科
    • 按地区分列的小儿配药市场(2015-2026年,百万美元)
  • 成人
    • 按地区划分的成人配药市场(2015-2026年,百万美元)
  • 老年病
    • 老年药市场,按地区,2015-2026(百万美元)
  • 兽医
    • 按地区划分的兽药批发市场(2015-2026年,百万美元)

第7章配药类型的配药市场

  • 主要细分趋势
  • 药物成分变更(PIA)
    • 按地区分列的药物成分变化(PIA)市场,2015-2026年,(百万美元)
  • 当前无法使用的药品制造(CUPM)
    • 当前不可用的药品制造(CUPM)市场,按地区分列,2015-2026,(百万美元)
  • 更改药物剂量(PDA)
    • 按地区分列的药物剂量变化(PDA)市场,2015-2026年,(百万美元)
  • 其他
    • 按地区分列的其他市场,2015-2026年,(百万美元)

第8章无菌配药市场

  • 主要细分趋势
  • 不育
    • 按地区分列的无菌点胶药市场,2015-2026年(百万美元)
  • 非无菌
    • 按地区划分的非处方药房市场,2015-2026年(百万美元)

第9章通过分销渠道分配药房市场

  • 主要细分趋势
  • 医院药房
    • 按地区分列的医院药房市场,2015-2026年(百万美元)
  • 配药
    • 按地区划分的药房市场,2015-2026年,(百万美元)
  • 其他
    • 按地区分列的其他市场,2015-2026年,(百万美元)

第10章按地区调剂药局市场

  • 区域趋势
  • 北美
    • 2015-2026年按国家分列的北美调剂药局市场(百万美元)
    • 2015-2026年按治疗领域划分的北美调剂药局市场(百万美元)
    • 2015-2026年北美调剂药局式场的产品分布(百万美元)
    • 北美调剂药局市场,按应用分列,2015-2026年(百万美元)
    • 2015-2026年北美调剂药局市场(按点胶类型)(百万美元)
    • 北美调剂药局市场,按无菌分列,2015-2026年(百万美元)
    • 2015-2026年北美经销渠道的调剂药局市场(百万美元)
    • 美国
    • 按应用划分的美国调剂药局市场,2015-2026年(百万美元)
    • 2015-2026年美国调剂药局市场(按点胶类型)(百万美元)
    • 2015年至2026年按无菌分列的美国调剂药局市场(百万美元)
    • 按分销渠道划分的美国调剂药局市场,2015-2026年(百万美元)
    • 加拿大
    • 按应用分列的加拿大调剂药局市场,2015-2026年(百万美元)
    • 2015-2026年加拿大调剂药局市场(按点胶类型)(百万美元)
    • 按无菌分列的加拿大调剂药局市场,2015-2026年(百万美元)
    • 2015-2026年加拿大经销渠道的调剂药局市场(百万美元)
  • 欧洲
    • 2015-2026年欧洲按地区分药市场(百万美元)
    • 按治疗领域划分的欧洲点胶药市场,2015-2026年(百万美元)
    • 欧洲点胶药市场的产品分布,2015-2026年(百万美元)
    • 按应用分列的欧洲点胶药市场,2015-2026年(百万美元)
    • 欧洲点胶药房市场(按点胶类型),2015-2026年(百万美元)
    • 欧洲不丹配药市场,按无菌分列,2015-2026年(百万美元)
    • 按分销渠道划分的欧洲制药市场,2015-2026年(百万美元)
    • 德国
    • 按应用分列的德国点胶药市场,2015-2026年(百万美元)
    • 2015-2026年按药房类型划分的德国药房市场(百万美元)
    • 德国无菌药房市场,2015-2026年(百万美元)
    • 2015-2026年全球经销渠道的德国配药市场(百万美元)
    • 英国
    • 按应用分列的英国点胶药市场,2015-2026年(百万美元)
    • 2015-2026年英国点胶药房市场(按点胶类型)(百万美元)
    • 英国点胶药房市场,按无菌度分,2015-2026(百万美元)
    • 按分销渠道划分的英国点胶药市场,2015-2026年(百万美元)
    • 意大利
    • 按应用分列的意大利点胶药市场,2015-2026年(百万美元)
    • 2015-2026年意大利点胶药房市场(按点胶类型)(百万美元)
    • 意大利无菌药房市场,2015-2026年(百万美元)
    • 按分销渠道分列的意大利点胶药市场,2015-2026年(百万美元)
    • 西班牙
    • 按应用分列的西班牙点胶药市场,2015-2026年(百万美元)
    • 2015-2026年西班牙按配药类型的配药市场(百万美元) 2015年20-2026年西班牙无菌药品配送市场(百万美元)
    • 按分销渠道划分的西班牙配药市场(2015-2026年,百万美元)
    • 法国
    • 按应用划分的法国点胶药市场,2015-2026年(百万美元)
    • 2015-2026年按药房类型划分的法国药房市场(百万美元)
    • 2015-2026年按无菌分列的法国点胶药市场(百万美元)
    • 按分销渠道划分的法国点胶药市场,2015-2026年(百万美元)
    • 波兰
    • 按应用分列的波兰药房市场,2015-2026年(百万美元)
    • 2015-2026年按点胶类型划分的点胶药房市场(百万美元)
    • 无菌药水配药市场,2015-2026年(百万美元)
    • 按分销渠道划分的波兰药房市场,2015-2026年(百万美元)
    • 乌克兰
    • 乌克兰点胶药房应用市场,2015-2026年(百万美元)
    • 按配药类型划分的乌克兰配药药房市场,2015-2026年(百万美元)
    • 乌克兰点胶药房市场,按无菌分列,2015-2026年(百万美元)
    • 按分销渠道划分的乌克兰点胶药市场,2015- 2026年(百万美元)
    • 希腊
    • 按应用分列的希腊点胶药房市场,2015-2026年(百万美元)
    • 希腊点胶药房市场(按点胶类型),2015- 2026年(百万美元)
    • 按无菌分列的希腊点胶药房市场,2015-2026年(百万美元)
    • 2015-2026年按分销渠道划分的希腊制药市场(百万美元)
    • 瑞典
    • 按应用分列的瑞典点胶药市场,2015-2026年(百万美元)
    • 瑞典点胶药房市场(按点胶类型),2015-2026年(百万美元)
    • 瑞典不丹分药市场,2015-2026年(百万美元)
    • 按分销渠道划分的瑞典点胶药市场,2015-2026年(百万美元)
    • 挪威
    • 按应用分列的挪威点胶药市场,2015-2026年(百万美元)
    • 2015-2026年按配药类型划分的挪威配药市场(百万美元)
    • 挪威无菌药房市场,2015-2026年(百万美元)
    • 按分销渠道划分的挪威点胶药市场,2015-2026年(百万美元)
    • 比利时
    • 按应用分列的比利时点胶药市场,2015-2026年(百万美元)
    • 比利时点胶药房市场(按点胶类型),2015-2026年(百万美元)
    • 比利时无菌药房市场,2015-2026年(百万美元)
    • 按分销渠道划分的比利时点胶药市场,2015-2026年(百万美元)
    • 捷克共和国
    • 按应用分列的捷克共和国点胶药房市场,2015-2026年(百万美元)
    • 2015-2026年捷克共和国按配药类型的配药市场(百万美元)
    • 捷克共和国无菌药房市场,2015-2026年(百万美元)
    • 按分销渠道划分的捷克共和国点药市场,2015-2026年(百万美元)
    • 芬兰
    • 芬兰按需分配药房市场,2015-2026年(百万美元)
    • 芬兰点胶药房市场(按点胶类型),2015-2026年(百万美元)
    • 芬兰无菌药房市场,2015-2026年(百万美元)
    • 按分销渠道划分的芬兰点胶药市场,2015-2026年(百万美元)
    • 俄罗斯
    • 俄罗斯肠胃外用药市场(2015-2026年,百万美元)
    • 按应用分列的俄罗斯点胶药市场,2015-2026年(百万美元)
    • 俄罗斯点胶药房市场(按点胶类型),2015-2026年(百万美元)
    • 俄罗斯点胶药房市场,按无菌分列,2015-2026年(百万美元)
    • 按分销渠道划分的俄罗斯点胶药市场,2015-2026年(百万美元)
  • 亚太地区
    • 2015-2026年按国家/地区划分的亚太点胶药市场(百万美元)
    • 亚太点胶药房市场,治疗学,2015-2026年(百万美元)
    • 2015-2026年亚太点胶药房市场产品(百万美元)
    • 按应用分列的亚太点胶药市场,2015-2026年(百万美元)
    • 2015-2026年亚太地区点胶药房市场(百万美元)
    • 按无菌分列的亚太点胶药房市场,2015-2026年(百万美元)
    • 2015-2026年按分销渠道划分的亚太点胶药市场(百万美元)
    • 中国
    • 按应用分列的中国点胶药市场,2015-2026年(百万美元)
    • 2015-2026年中国点胶药市场(按点胶类型)(百万美元)
    • 2015-2026年中国无菌点胶药市场(百万美元)
    • 按分销渠道分列的中国点胶药市场,2015-2026年(百万美元)
    • 印度
    • 按应用分列的印度点胶药市场,2015-2026年(百万美元)
    • 2015-2026年印度点胶药房市场分布(百万美元)
    • 印度无菌药房市场,2015-2026年(百万美元)
    • 2015-2026年印度经销渠道的配药市场(百万美元)
    • 日本
    • 日本点药市场,按应用分列,2015-2026年(百万美元)
    • 2015-2026年日本点胶药房市场(按点胶类型)(百万美元)
    • 日本点胶药房市场,无菌性,2015-2026年(百万美元)
    • 2015-2026年按分销渠道划分的日本点胶药市场(百万美元)
    • 新加坡
    • 2015-2026年新加坡点胶药房市场应用(百万美元)
    • 新加坡点胶药房市场(按点胶类型),2015-2026年(百万美元)
    • 新加坡无菌药房市场,2015-2026年(百万美元)
    • 按分销渠道划分的新加坡点胶药市场,2015-2026年(百万美元)
    • 澳大利亚
    • 按应用分列的澳大利亚点胶药市场,2015-2026年(百万美元)
    • 2015-2026年澳大利亚按配药类型的配药市场(百万美元)
    • 澳大利亚无菌药房市场,2015-2026年(百万美元)
    • 按分销渠道划分的澳大利亚点胶药市场,2015-2026年(百万美元)
  • 拉丁美洲
    • 2015-2026年按国家分列的拉丁美洲点胶药市场(百万美元)
    • 2015-2026年按治疗领域分列的拉丁美洲点胶药市场(百万美元)
    • 2015-2026年拉丁美洲点胶药市场的产品分布(百万美元)
    • 2015-2026年按应用分列的拉丁美洲点胶药市场(百万美元)
    • 2015-2026年按药房类型划分的拉丁美洲药房市场(百万美元)
    • 2015-2026年按无菌分列的拉丁美洲点胶药市场(百万美元)
    • 2015-2026年按分销渠道划分的拉丁美洲点胶药市场(百万美元)
    • 阿根廷
    • 巴西
    • 按应用分列的巴西点胶药市场,2015-2026年(百万美元)
    • 巴西点胶药房市场(按点胶类型),2015-2026年(百万美元)
    • 巴西无菌药房市场,2015-2026年(百万美元)
    • 按分销渠道划分的巴西点胶药市场,2015-2026年(百万美元)
    • 墨西哥
    • 按应用分列的墨西哥点胶药市场,2015-2026年(百万美元)
    • 2015-2026年墨西哥按配药类型的配药市场(百万美元)
    • 墨西哥无菌药房市场,2015-2026年(百万美元)
    • 按分销渠道划分的墨西哥点胶药市场,2015-2026年(百万美元)
  • 中东/非洲
    • 2015-2026年按国家分列的中东和非洲点药市场(百万美元)
    • 按治疗领域分列的中东/非洲点胶药市场,2015-2026年(百万美元)
    • 中东/非洲点胶药房市场产品分布,2015-2026年(百万美元)
    • 按应用分列的中东和非洲点胶药市场,2015-2026年(百万美元)
    • 2015-2026年按药房类型划分的中东和非洲药房市场(百万美元)
    • 中东/非洲点胶药房市场,按无菌度分,2015-2026(百万美元)
    • 按分销渠道划分的中东/非洲点胶药市场,2015-2026年(百万美元)
    • 南非
    • 按应用分列的南非点胶药市场,2015-2026年(百万美元)
    • 2015-2026年按分配类型划分的南非配药市场(百万美元)
    • 2015-2026年按无菌分列的南非点胶药市场(百万美元)
    • 按分销渠道划分的南非点胶药市场,2015-2026年(百万美元)
    • 阿拉伯联合酋长国
    • 按应用分列的阿联酋点胶药市场,2015-2026年(百万美元)
    • 2015-2026年按配药类型划分的阿联酋配药市场(百万美元)
    • 阿联酋无菌药房市场,2015-2026年(百万美元)
    • 阿联酋配药市场按分销渠道划分,2015-2026年(百万美元)
    • 沙特阿拉伯
    • 按应用分列的沙特阿拉伯点胶药房市场,2015-2026年(百万美元)
    • 沙特阿拉伯点胶药房市场(按点胶类型),2015-2026年(百万美元)
    • 无菌生产的沙特阿拉伯点胶药房市场,2015-2026年(百万美元)
    • 按分销渠道划分的沙特阿拉伯点胶药房市场,2015-2026年(百万美元)
    • 卡塔尔
    • 按应用分列的卡塔尔点胶药房市场,2015-2026年(百万美元)
    • 卡塔尔药房市场,按混合类型分列,2015-2026年(百万美元)
    • 卡塔尔医药市场,按无菌分,2015-2026(百万美元)
    • 按分销渠道划分的卡塔尔点胶药市场,2015-2026年(百万美元)
    • 科威特
    • 科威特的配药市场按应用分列,2015-2026年(百万美元)
    • 科威特点胶药房市场(按点胶类型),2015-2026年(百万美元)
    • 科威特无菌药房市场,2015-2026年(百万美元)
    • 科威特的分销市场按分销渠道分布的药房市场,2015-2026年(百万美元)

第11章公司简介

  • Competitive Landscape
  • B. Braun Medical Inc.
  • Dougherty's Pharmacy, Inc.
  • Fagron
  • Fresenius Kabi
  • Institutional Pharmacy Solutions
  • Clinigen Group PLC
  • Lorraine's Pharmacy
  • McGuff Company Inc (McGuff Compounding Pharmacy Services)
  • Pencol Compounding Pharmacy
  • Athenex Pharma Solutions (Athenex Inc.)
  • Rx3 Compounding Pharmacy
  • Triangle Compounding Pharmacies
  • Nephron Pharmaceuticals Corporation
  • Wedgewood Village Pharmacy, Inc.
目录
Product Code: 749

Title:
Compounding Pharmacies Market Size By Therapeutic Area (Hormone Replacement, Pain Management, Dermatology Applications, Specialty Drugs, Nutritional Supplements), By Product (Oral {Solid Preparations [Tablets, Capsules, Granules, Powder], Liquid Preparations [Solutions, Suspension, Emulsion, Syrup], Topical [Ointments, Creams, Gels, Pastes], Rectal [Suppositories, Enema], Parenteral [LVP, SVP]}, Nasal, Ophthalmic, Otic), By Application (Pediatric, Adult, Geriatric, Veterinary), By Compounding Type (Pharmaceutical Ingredient Alteration [PIA], Currently Unavailable Pharmaceutical Manufacturing [CUPM], Pharmaceutical Dosage Alteration [PDA]), By Sterility (Sterile, Non-sterile), By Distribution Channel (Hospital Pharmacy, Compounding Pharmacy), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026.

The compounding pharmacies market is projected to record a remunerative growth rate over the coming years owing to the growing demand for customized medicine and drugs among patients to help treat a plethora of different ailments. A compounding pharmacy generally makes customized drugs and medications which are not available commercially or over the counter. These pharmacies can formulate alternative forms of drugs, drug doses, sugar-free drugs, etc.

The compounding pharmacies market is bifurcated in terms of therapeutic area, product, application, compounding type, sterility, and distribution channels.

Based on therapeutic area, the compounding pharmacies market is classified into nutritional supplements, specialty drugs, dermatology applications, pain management, hormone replacement, and others.

The nutritional supplements segment accounted for a market value of more than $580 million in 2019. Nutritional supplements are dietary supplement that is intended to provide nutrients. The examples include proteins, minerals, amino acids, vitamins, and other nutritional substances. These products are generally taken in the form of tablet, capsule or in liquid form.

With respect to product, the compounding pharmacies market is categorized into otic, ophthalmic, nasal, parenteral, rectal, topical, and oral. The nasal product segment accounted for around 8% market share in 2019. Nasal administration is a route of administration wherein drugs are insufflated through the nose.

Nasal delivery helps in addressing problems which are related to drug degradation, adverse events in the gastrointestinal tract, slow absorption, poor bioavailability, it also avoids the first-pass metabolism in the liver.

In terms of application, the compounding pharmacies market is bifurcated into veterinary, geriatric, adult, and children. The geriatric application segment is likely to record a CAGR of around 6.5% by the end of the analysis period. Surge in number of companion animals will foster the segmental growth.

Based on compounding type, the compounding pharmacies market is segmented into Pharmaceutical Dosage Alteration (PDA), Currently Unavailable Pharmaceutical Manufacturing (CUPM), Pharmaceutical Ingredient Alteration (PIA), and others.

The CUPM segment held a market value of more than $2.2 billion in 2019. Medicine shortages can occur for several reasons such as quality problems & manufacturing discontinuations as well as delays, owing to the reduced use or fallen manufacturer profits, that might be related to the launch of a new drug.

With respect to sterility, the compounding pharmacies market is divided into nonsterile dosage forms and sterile dosage form. The sterile dosage form will witness a CAGR of around 6.5% over the forecast time period. Increasing incidence of chronic diseases is expected to increase the need for sterile medications.

Based on distribution channels, the compounding pharmacies market is classified into compounding pharmacies, hospital pharmacy, and others. The others segment represented a market value of more than $850 million in 2019 and will continue to show appreciative growth in coming years.

Table of Contents

Chapter 1. Methodology

  • 1.1. Methodology
  • 1.2. Market definitions
  • 1.3. Forecast parameters
  • 1.4. Data sources
    • 1.4.1. Secondary
      • 1.4.1.1. Paid sources
      • 1.4.1.2. Unpaid sources
    • 1.4.2. Primary

Chapter 2. Executive Summary

  • 2.1. Compounding pharmacies industry 360 degree synopsis, 2015 - 2026
    • 2.1.1. Business trends
    • 2.1.2. Therapeutic area trends
    • 2.1.3. Product trends
    • 2.1.4. Application trends
    • 2.1.5. Compounding type trends
    • 2.1.6. Sterility trends
    • 2.1.7. Distribution channel trends
    • 2.1.8. Regional trends

Chapter 3. Compounding Pharmacies Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2015 - 2026
  • 3.3. Industry ecosystem analysis
    • 3.3.1. Distribution channel analysis
  • 3.4. Industry impact forces
    • 3.4.1. Growth drivers
      • 3.4.1.1. Rising geriatric population and improved life expectancy across the globe
      • 3.4.1.2. Rising adoption of customized medicine in the developed regions
      • 3.4.1.3. Shortage of drugs across the globe
      • 3.4.1.4. Benefits of compounded medication
      • 3.4.1.5. Growing drug failure rate
    • 3.4.2. Industry pitfalls and challenges
      • 3.4.2.1. Lack of skilled lab technicians and pharmacists in developed economies
      • 3.4.2.2. High cost of equipment and maintenance of sterile environment
      • 3.4.2.3. Volatile regulatory scenario
      • 3.4.2.4. Consumer perception towards compounded drugs
  • 3.5. Growth potential analysis
    • 3.5.1. By therapeutic area
    • 3.5.2. By product
    • 3.5.3. By application
    • 3.5.4. By compounding type
    • 3.5.5. By sterility
    • 3.5.6. By distribution channel
  • 3.6. Regulatory landscape
    • 3.6.1. U.S.
    • 3.6.2. Europe
    • 3.6.3. Australia
  • 3.7. Reimbursement landscape
    • 3.7.1. U.S.
    • 3.7.2. Europe
    • 3.7.3. Australia
  • 3.8. Cost analysis of compounded medications
  • 3.9. Compounding pharmacies count, by region 2019
    • 3.9.1. North America
    • 3.9.2. Europe
    • 3.9.3. Asia Pacific
    • 3.9.4. Latin America
    • 3.9.5. Middle East and Africa
  • 3.10. Innovative compounding technologies
    • 3.10.1. Web-based quality management system
    • 3.10.2. Digital tools
  • 3.11. Porter's analysis
  • 3.12. PESTEL Analysis

Chapter 4. Compounding Pharmacies Market, By Therapeutic Area

  • 4.1. Key segment trends
  • 4.2. Hormone replacement
    • 4.2.1. Hormone replacement market, by region, 2015 - 2026, (USD Million)
  • 4.3. Pain management
    • 4.3.1. Pain management market, by region, 2015 - 2026, (USD Million)
  • 4.4. Dermatology
    • 4.4.1. Dermatology market, by region, 2015 - 2026, (USD Million)
  • 4.5. Specialty drugs
    • 4.5.1. Specialty drugs market, by region, 2015 - 2026, (USD Million)
  • 4.6. Nutritional supplements
    • 4.6.1. Nutritional supplements market, by region, 2015 - 2026, (USD Million)
  • 4.7. Others
    • 4.7.1. Others market, by region, 2015 - 2026, (USD Million)

Chapter 5. Compounding Pharmacies Market, By Product

  • 5.1. Key segment trends
  • 5.2. Oral
    • 5.2.1. Oral market by region, 2015 - 2026 (USD Million)
    • 5.2.2. Solid preparations
      • 5.2.2.1. Compounding pharmacies solid preparations market, by region, 2015 - 2026, (USD million)
      • 5.2.2.2. Tablets
        • 5.2.2.2.1. Compounding pharmacies tablets market, by region, 2015 - 2026, (USD Million)
      • 5.2.2.3. Capsules
        • 5.2.2.3.1. Compounding pharmacies capsules market, by region, 2015 - 2026, (USD Million)
      • 5.2.2.4. Granules
        • 5.2.2.4.1. Compounding pharmacies granules market, by region, 2015 - 2026, (USD Million)
      • 5.2.2.5. Powder
        • 5.2.2.5.1. Compounding pharmacies powder market, by region, 2015 - 2026, (USD Million)
      • 5.2.2.6. Others
        • 5.2.2.6.1. Compounding pharmacies others market, by region, 2015 - 2026, (USD Million)
    • 5.2.3. Liquid preparations
      • 5.2.3.1. Compounding pharmacies liquid preparations market, by region, 2015 - 2026, (USD Million)
      • 5.2.3.2. Solutions
        • 5.2.3.2.1. Compounding pharmacies solutions market, by region, 2015 - 2026, (USD Million)
      • 5.2.3.3. Suspension
        • 5.2.3.3.1. Compounding pharmacies suspension market, by region, 2015 - 2026, (USD Million)
      • 5.2.3.4. Emulsion
        • 5.2.3.4.1. Compounding pharmacies emulsion market, by region, 2015 - 2026, (USD Million)
      • 5.2.3.5. Syrup
        • 5.2.3.5.1. Compounding pharmacies syrup market, by region, 2015 - 2026, (USD Million)
      • 5.2.3.6. Others
        • 5.2.3.6.1. Compounding pharmacies others market, by region, 2015 - 2026, (USD Million)
  • 5.3. Topical
    • 5.3.1. Topical market, by region, 2015 - 2026, (USD Million)
    • 5.3.2. Ointments
      • 5.3.2.1. Compounding pharmacies ointments market, by region, 2015 - 2026, (USD Million)
    • 5.3.3. Creams
      • 5.3.3.1. Compounding pharmacies creams market, by region, 2015 - 2026, (USD Million)
    • 5.3.4. Gels
      • 5.3.4.1. Compounding pharmacies gels market, by region, 2015 - 2026, (USD Million)
    • 5.3.5. Pastes
      • 5.3.5.1. Compounding pharmacies pastes market, by region, 2015 - 2026, (USD Million)
    • 5.3.6. Others
      • 5.3.6.1. Compounding pharmacies others market, by region, 2015 - 2026, (USD Million)
  • 5.4. Rectal
    • 5.4.1. Rectal market by region, 2015 - 2026 (USD Million)
    • 5.4.2. Suppositories
      • 5.4.2.1. Compounding pharmacies suppositories market, by region, 2015 - 2026, (USD Million)
    • 5.4.3. Enema
      • 5.4.3.1. Compounding pharmacies enema market, by region, 2015 - 2026, (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Compounding pharmacies others market, by region, 2015 - 2026, (USD Million)
  • 5.5. Parenteral
    • 5.5.1. Parenteral market by region, 2015 - 2026 (USD Million)
    • 5.5.2. Small volume parenteral (SVP) solutions
      • 5.5.2.1. Small volume parenteral (SVP) solutions market by region, 2015 - 2026 (USD Million)
    • 5.5.3. Large Volume Parenteral (LVP) Solutions
      • 5.5.3.1. Large Volume Parenteral (LVP) Solutions market by region, 2015 - 2026 (USD Million)
  • 5.6. Nasal
    • 5.6.1. Nasal market by region, 2015 - 2026 (USD Million)
  • 5.7. Ophthalmic
    • 5.7.1. Ophthalmic market by region, 2015 - 2026 (USD Million)
  • 5.8. Otic
    • 5.8.1. Otic market by region, 2015 - 2026 (USD Million)

Chapter 6. Compounding Pharmacies Market, By Application

  • 6.1. Key segment trends
  • 6.2. Paediatric
    • 6.2.1. Paediatric compounding pharmacies market, by region, 2015 - 2026, (USD Million)
  • 6.3. Adult
    • 6.3.1. Adult compounding pharmacies market, by region 2015 - 2026, (USD Million)
  • 6.4. Geriatric
    • 6.4.1. Geriatric compounding pharmacies market, by region 2015 - 2026, (USD Million)
  • 6.5. Veterinary
    • 6.5.1. Veterinary compounding pharmacies market, by region 2015 - 2026, (USD Million)

Chapter 7. Compounding Pharmacies Market, By Compounding Type

  • 7.1. Key segment trends
  • 7.2. Pharmaceutical Ingredient Alteration (PIA)
    • 7.2.1. Pharmaceutical ingredient alteration (PIA) market, by region, 2015 - 2026, (USD Million)
  • 7.3. Currently Unavailable Pharmaceutical Manufacturing (CUPM)
    • 7.3.1. Currently unavailable pharmaceutical manufacturing (CUPM) market, by region, 2015 - 2026, (USD Million)
  • 7.4. Pharmaceutical Dosage Alteration (PDA)
    • 7.4.1. Pharmaceutical dosage alteration (PDA) market, by region, 2015 - 2026, (USD Million)
  • 7.5. Others
    • 7.5.1. Others market, by region, 2015 - 2026, (USD Million)

Chapter 8. Compounding Pharmacies Market, By Sterility

  • 8.1. Key segment trends
  • 8.2. Sterile
    • 8.2.1. Sterile compounding pharmacies market, by region, 2015 - 2026, (USD Million)
  • 8.3. Non-sterile
    • 8.3.1. Non-sterile compounding pharmacies market, by region, 2015 - 2026, (USD Million)

Chapter 9. Compounding Pharmacies Market, By Distribution Channel

  • 9.1. Key segment trends
  • 9.2. Hospital Pharmacy
    • 9.2.1. Hospital pharmacy market, by region, 2015 - 2026, (USD Million)
  • 9.3. Compounding pharmacy
    • 9.3.1. Compounding pharmacy market, by region, 2015 - 2026, (USD Million)
  • 9.4. Others
    • 9.4.1. Others market, by region, 2015 - 2026, (USD Million)

Chapter 10. Compounding Pharmacies Market, By Region

  • 10.1. Key regional trends
  • 10.2. North America
    • 10.2.1. North America compounding pharmacies market, by country, 2015 - 2026 (USD Million)
    • 10.2.2. North America compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
    • 10.2.3. North America compounding pharmacies market, by product, 2015 - 2026 (USD Million)
      • 10.2.3.1. North America compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.2.3.1.1. North America compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.2.3.1.2. North America compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.2.3.2. North America compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.2.3.3. North America compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.2.3.4. North America compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.2.4. North America compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.2.5. North America compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.2.6. North America compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.2.7. North America compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.2.8. U.S.
      • 10.2.8.1. U.S. compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.2.8.2. U.S. compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.2.8.2.1. U.S. compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.2.8.2.1.1. U.S. compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.2.8.2.1.2. U.S. compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.2.8.3. U.S. compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.2.8.4. U.S. compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.2.8.5. U.S. compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.2.9. U.S. compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.2.10. U.S. compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.2.11. U.S. compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.2.12. U.S. compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.2.13. Canada
      • 10.2.13.1. Canada compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.2.13.2. Canada compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.2.13.2.1. Canada compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.2.13.2.1.1. Canada compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.2.13.2.1.2. Canada compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.2.13.3. Canada compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.2.13.4. Canada compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.2.13.5. Canada compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.2.14. Canada compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.2.15. Canada compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.2.16. Canada compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.2.17. Canada compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
  • 10.3. Europe
    • 10.3.1. Europe compounding pharmacies market, by country, 2015 - 2026 (USD Million)
    • 10.3.2. Europe compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
    • 10.3.3. Europe compounding pharmacies market, by product, 2015 - 2026 (USD Million)
      • 10.3.3.1. Europe compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.3.3.1.1. Europe compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.3.3.1.2. Europe compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.3.3.2. Europe compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.3.3.3. Europe compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.3.3.4. Europe compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.3.4. Europe compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.3.5. Europe compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.3.6. Europe compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.3.7. Europe compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.3.8. Germany
      • 10.3.8.1. Germany compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.3.8.2. Germany compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.3.8.2.1. Germany compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.3.8.2.1.1. Germany compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.3.8.2.1.2. Germany compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.3.8.3. Germany compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.3.8.4. Germany compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.3.8.5. Germany compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.3.9. Germany compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.3.10. Germany compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.3.11. Germany compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.3.12. Germany compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.3.13. UK
      • 10.3.13.1. UK compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.3.13.2. UK compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.3.13.2.1. UK compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.3.13.2.1.1. UK compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.3.13.2.1.2. UK compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.3.13.3. UK compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.3.13.4. UK compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.3.13.5. UK compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.3.14. UK compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.3.15. UK compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.3.16. UK compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.3.17. UK compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.3.18. Italy
      • 10.3.18.1. Italy compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.3.18.2. Italy compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.3.18.2.1. Italy compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.3.18.2.2. Italy compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
      • 10.3.18.3. Italy compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.3.18.4. Italy compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.3.18.5. Italy compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.3.18.6. Italy compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.3.19. Italy compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.3.20. Italy compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.3.21. Italy compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.3.22. Italy compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.3.23. Spain
      • 10.3.23.1. Spain compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.3.23.2. Spain compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.3.23.2.1. Spain compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.3.23.2.2. Spain compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.3.23.2.3. Spain compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.3.23.3. Spain compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.3.23.4. Spain compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.3.23.5. Spain compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.3.24. Spain compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.3.25. Spain compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.3.26. Spain compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.3.27. Spain compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.3.28. France
      • 10.3.28.1. France compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.3.28.2. France compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.3.28.2.1. France compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.3.28.2.1.1. France compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.3.28.2.1.2. France compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.3.28.3. France compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.3.28.4. France compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.3.28.5. France compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.3.29. France compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.3.30. France compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.3.31. France compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.3.32. France compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.3.33. Poland
      • 10.3.33.1. Poland compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.3.33.2. Poland compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.3.33.2.1. Poland compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.3.33.2.2. Poland compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.3.33.2.3. Poland compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.3.33.3. Poland compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.3.33.4. Poland compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.3.33.5. Poland compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.3.34. Poland compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.3.35. Poland compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.3.36. Poland compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.3.37. Poland compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.3.38. Ukraine
      • 10.3.38.1. Ukraine compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.3.38.2. Ukraine compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.3.38.2.1. Ukraine compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.3.38.2.1.1. Ukraine compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.3.38.2.1.2. Ukraine compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.3.38.3. Ukraine compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.3.38.4. Ukraine compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.3.38.5. Ukraine compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.3.39. Ukraine compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.3.40. Ukraine compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.3.41. Ukraine compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.3.42. Ukraine compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.3.43. Greece
      • 10.3.43.1. Greece compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.3.43.2. Greece compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.3.43.2.1.1. Greece compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.3.43.2.1.2. Greece compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
      • 10.3.43.3. Greece compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.3.43.4. Greece compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.3.43.5. Greece compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.3.43.6. Greece compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.3.44. Greece compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.3.45. Greece compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.3.46. Greece compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.3.47. Greece compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.3.48. Sweden
      • 10.3.48.1. Sweden compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.3.48.2. Sweden compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.3.48.2.1. Sweden compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.3.48.2.1.1. Sweden compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.3.48.2.1.2. Sweden compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.3.48.3. Sweden compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.3.48.4. Sweden compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.3.48.5. Sweden compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.3.49. Sweden compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.3.50. Sweden compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.3.51. Sweden compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.3.52. Sweden compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.3.53. Norway
      • 10.3.53.1. Norway compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.3.53.2. Norway compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.3.53.2.1. Norway compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.3.53.2.1.1. Norway compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.3.53.2.1.2. Norway compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.3.53.3. Norway compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.3.53.4. Norway compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.3.53.5. Norway compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.3.54. Norway compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.3.55. Norway compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.3.56. Norway compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.3.57. Norway compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.3.58. Belgium
      • 10.3.58.1. Belgium compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.3.58.2. Belgium compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.3.58.2.1. Belgium compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.3.58.2.1.1. Belgium compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.3.58.2.1.2. Belgium compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.3.58.3. Belgium compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.3.58.4. Belgium compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.3.58.5. Belgium compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.3.59. Belgium compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.3.60. Belgium compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.3.61. Belgium compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.3.62. Belgium compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.3.63. Czech Republic
      • 10.3.63.1. Czech Republic compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.3.63.2. Czech Republic compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.3.63.2.1. Czech Republic compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.3.63.2.1.1. Czech Republic compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.3.63.2.1.2. Czech Republic compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.3.63.3. Czech Republic compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.3.63.4. Czech Republic compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.3.63.5. Czech Republic compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.3.64. Czech Republic compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.3.65. Czech Republic compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.3.66. Czech Republic compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.3.67. Czech Republic compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.3.68. Finland
      • 10.3.68.1. Finland compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.3.68.2. Finland compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.3.68.2.1. Finland compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.3.68.2.1.1. Finland compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.3.68.2.1.2. Finland compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.3.68.3. Finland compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.3.68.4. Finland compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.3.68.5. Finland compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.3.69. Finland compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.3.70. Finland compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.3.71. Finland compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.3.72. Finland compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.3.73. Russia
      • 10.3.73.1. Russia compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.3.73.2. Russia compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.3.73.2.1. Russia compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.3.73.2.2. Russia compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
      • 10.3.73.3. Russia compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.3.73.4. Russia compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.3.73.5. Russia compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
    • 10.3.74. Russia compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.3.75. Russia compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.3.76. Russia compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.3.77. Russia compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.3.78. Russia compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
  • 10.4. Asia Pacific
    • 10.4.1. Asia Pacific compounding pharmacies market, by country, 2015 - 2026 (USD Million)
    • 10.4.2. Asia Pacific compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
    • 10.4.3. Asia Pacific compounding pharmacies market, by product, 2015 - 2026 (USD Million)
      • 10.4.3.1. Asia Pacific compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.4.3.1.1. Asia Pacific compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.4.3.1.2. Asia Pacific compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.4.3.2. Asia Pacific compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.4.3.3. Asia Pacific compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.4.3.4. Asia Pacific compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.4.4. Asia Pacific compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.4.5. Asia Pacific compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.4.6. Asia Pacific compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.4.7. Asia Pacific compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.4.8. China
      • 10.4.8.1. China compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.4.8.2. China compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.4.8.2.1. China compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
          • 10.4.8.2.1.1. China compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
          • 10.4.8.2.1.2. China compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.4.8.3. China compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.4.8.4. China compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.4.8.5. China compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.4.9. China compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.4.10. China compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.4.11. China compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.4.12. China compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.4.13. India
      • 10.4.13.1. India compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.4.13.2. India compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.4.13.2.1. India compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
          • 10.4.13.2.1.1. India compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
          • 10.4.13.2.1.2. India compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.4.13.3. India compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.4.13.4. India compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.4.13.5. India compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.4.14. India compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.4.15. India compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.4.16. India compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.4.17. India compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.4.18. Japan
      • 10.4.18.1. Japan compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.4.18.2. Japan compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.4.18.2.1. Japan compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
          • 10.4.18.2.1.1. Japan compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
          • 10.4.18.2.1.2. Japan compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.4.18.3. Japan compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.4.18.4. Japan compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.4.18.5. Japan compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.4.19. Japan compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.4.20. Japan compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.4.21. Japan compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.4.22. Japan compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.4.23. Singapore
      • 10.4.23.1. Singapore compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.4.23.2. Singapore compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.4.23.2.1. Singapore compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
          • 10.4.23.2.1.1. Singapore compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
          • 10.4.23.2.1.2. Singapore compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.4.23.3. Singapore compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.4.23.4. Singapore compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.4.23.5. Singapore compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.4.24. Singapore compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.4.25. Singapore compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.4.26. Singapore compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.4.27. Singapore compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.4.28. Australia
      • 10.4.28.1. Australia compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.4.28.2. Australia compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.4.28.2.1. Australia compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
          • 10.4.28.2.1.1. Australia compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
          • 10.4.28.2.1.2. Australia compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.4.28.3. Australia compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.4.28.4. Australia compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.4.28.5. Australia compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.4.29. Australia compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.4.30. Australia compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.4.31. Australia compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.4.32. Australia compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
  • 10.5. Latin America
    • 10.5.1. Latin America compounding pharmacies market, by country, 2015 - 2026 (USD Million)
    • 10.5.2. Latin America compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
    • 10.5.3. Latin America compounding pharmacies market, by product, 2015 - 2026 (USD Million)
      • 10.5.3.1. Latin America compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.5.3.1.1. Latin America compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.5.3.1.2. Latin America compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.5.3.2. Latin America compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.5.3.3. Latin America compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.5.3.4. Latin America compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.5.4. Latin America compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.5.5. Latin America compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.5.6. Latin America compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.5.7. Latin America compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.5.8. Argentina
      • 10.5.8.1. Argentina compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.5.8.2. Argentina compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.5.8.2.1. Argentina compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
          • 10.5.8.2.1.1. Argentina compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
          • 10.5.8.2.1.2. Argentina compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.5.8.3. Argentina compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.5.8.4. Argentina compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.5.8.5. Argentina compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
      • 10.5.8.6. Argentina compounding pharmacies market, by application, 2015 - 2026 (USD Million)
      • 10.5.8.7. Argentina compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
      • 10.5.8.8. Argentina compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
      • 10.5.8.9. Argentina compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.5.9. Brazil
      • 10.5.9.1. Brazil compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.5.9.2. Brazil compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.5.9.2.1. Brazil compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
          • 10.5.9.2.1.1. Brazil compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
          • 10.5.9.2.1.2. Brazil compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.5.9.3. Brazil compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.5.9.4. Brazil compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.5.9.5. Brazil compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.5.10. Brazil compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.5.11. Brazil compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.5.12. Brazil compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.5.13. Brazil compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.5.14. Mexico
      • 10.5.14.1. Mexico compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.5.14.2. Mexico compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.5.14.2.1. Mexico compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
          • 10.5.14.2.1.1. Mexico compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
          • 10.5.14.2.1.2. Mexico compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.5.14.3. Mexico compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.5.14.4. Mexico compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.5.14.5. Mexico compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.5.15. Mexico compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.5.16. Mexico compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.5.17. Mexico compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.5.18. Mexico compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
  • 10.6. Middle East & Africa
    • 10.6.1. Middle East & Africa compounding pharmacies market, by country, 2015 - 2026 (USD Million)
    • 10.6.2. Middle East & Africa compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
    • 10.6.3. Middle East & Africa compounding pharmacies market, by product, 2015 - 2026 (USD Million)
      • 10.6.3.1. Middle East & Africa compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
        • 10.6.3.1.1. Middle East & Africa compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
        • 10.6.3.1.2. Middle East & Africa compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.6.3.2. Middle East & Africa compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.6.3.3. Middle East & Africa compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.6.3.4. Middle East & Africa compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.6.4. Middle East & Africa compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.6.5. Middle East & Africa compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.6.6. Middle East & Africa compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.6.7. Middle East & Africa compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.6.8. South Africa
      • 10.6.8.1. South Africa compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.6.8.2. South Africa compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.6.8.2.1. South Africa compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
          • 10.6.8.2.1.1. South Africa compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
          • 10.6.8.2.1.2. South Africa compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.6.8.3. South Africa compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.6.8.4. South Africa compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.6.8.5. South Africa compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.6.9. South Africa compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.6.10. South Africa compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.6.11. South Africa compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.6.12. South Africa compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.6.13. UAE
      • 10.6.13.1. UAE compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.6.13.2. UAE compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.6.13.2.1. UAE compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
          • 10.6.13.2.1.1. UAE compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
          • 10.6.13.2.1.2. UAE compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.6.13.3. UAE compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.6.13.4. UAE compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.6.13.5. UAE compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.6.14. UAE compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.6.15. UAE compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.6.16. UAE compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.6.17. UAE compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.6.18. Saudi Arabia
      • 10.6.18.1. Saudi Arabia compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.6.18.2. Saudi Arabia compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.6.18.2.1. Saudi Arabia compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
          • 10.6.18.2.1.1. Saudi Arabia compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
          • 10.6.18.2.1.2. Saudi Arabia compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.6.18.3. Saudi Arabia compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.6.18.4. Saudi Arabia compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.6.18.5. Saudi Arabia compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.6.19. Saudi Arabia compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.6.20. Saudi Arabia compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.6.21. Saudi Arabia compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.6.22. Saudi Arabia compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.6.23. Qatar
      • 10.6.23.1. Qatar compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.6.23.2. Qatar compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.6.23.2.1. Qatar compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
          • 10.6.23.2.1.1. Qatar compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
          • 10.6.23.2.1.2. Qatar compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.6.23.3. Qatar compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.6.23.4. Qatar compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.6.23.5. Qatar compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.6.24. Qatar compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.6.25. Qatar compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.6.26. Qatar compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.6.27. Qatar compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
    • 10.6.28. Kuwait
      • 10.6.28.1. Kuwait compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
      • 10.6.28.2. Kuwait compounding pharmacies market, by product, 2015 - 2026 (USD Million)
        • 10.6.28.2.1. Kuwait compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
          • 10.6.28.2.1.1. Kuwait compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
          • 10.6.28.2.1.2. Kuwait compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
      • 10.6.28.3. Kuwait compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
      • 10.6.28.4. Kuwait compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
      • 10.6.28.5. Kuwait compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
    • 10.6.29. Kuwait compounding pharmacies market, by application, 2015 - 2026 (USD Million)
    • 10.6.30. Kuwait compounding pharmacies market, by compounding type, 2015 - 2026 (USD Million)
    • 10.6.31. Kuwait compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
    • 10.6.32. Kuwait compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)

Chapter 11. Company Profiles

  • 11.1. Competitive Landscape
    • 11.1.1. Strategy Dashboard, 2019
  • 11.2. B. Braun Medical Inc.
    • 11.2.1. Business Overview
    • 11.2.2. Financial data
    • 11.2.3. Product landscape
    • 11.2.4. Strategic outlook
    • 11.2.5. SWOT analysis
  • 11.3. Dougherty's Pharmacy, Inc.
    • 11.3.1. Business overview
    • 11.3.2. Financial data
    • 11.3.3. Product landscape
    • 11.3.4. Strategic outlook
    • 11.3.5. SWOT analysis
  • 11.4. Fagron
    • 11.4.1. Business overview
    • 11.4.2. Financial data
    • 11.4.3. Product landscape
    • 11.4.4. Strategic outlook
    • 11.4.5. SWOT analysis
  • 11.5. Fresenius Kabi
    • 11.5.1. Business overview
    • 11.5.2. Financial Data
    • 11.5.3. Product landscape
    • 11.5.4. Strategic outlook
    • 11.5.5. SWOT analysis
  • 11.6. Institutional Pharmacy Solutions
    • 11.6.1. Business overview
    • 11.6.2. Financial data
    • 11.6.3. Product landscape
    • 11.6.4. SWOT analysis
  • 11.7. Clinigen Group PLC
    • 11.7.1. Business overview
    • 11.7.2. Financial data
    • 11.7.3. Product landscape
    • 11.7.4. Strategic outlook
    • 11.7.5. SWOT analysis
  • 11.8. Lorraine's Pharmacy
    • 11.8.1. Business overview
    • 11.8.2. Financial data
    • 11.8.3. Product landscape
    • 11.8.4. SWOT analysis
  • 11.9. McGuff Company Inc (McGuff Compounding Pharmacy Services)
    • 11.9.1. Business overview
    • 11.9.2. Financial data
    • 11.9.3. Product landscape
    • 11.9.4. SWOT analysis
  • 11.10. Pencol Compounding Pharmacy
    • 11.10.1. Business overview
    • 11.10.2. Financial data
    • 11.10.3. Product landscape
    • 11.10.4. SWOT analysis
  • 11.11. Athenex Pharma Solutions (Athenex Inc.)
    • 11.11.1. Business overview
    • 11.11.2. Financial data
    • 11.11.3. Product landscape
    • 11.11.4. Strategic outlook
    • 11.11.5. SWOT analysis
  • 11.12. Rx3 Compounding Pharmacy
    • 11.12.1. Business overview
    • 11.12.2. Financial data
    • 11.12.3. Product landscape
    • 11.12.4. SWOT analysis
  • 11.13. Triangle Compounding Pharmacies
    • 11.13.1. Business overview
    • 11.13.2. Financial data
    • 11.13.3. Product landscape
    • 11.13.4. SWOT analysis
  • 11.14. Nephron Pharmaceuticals Corporation
    • 11.14.1. Business overview
    • 11.14.2. Financial data
    • 11.14.3. Product landscape
    • 11.14.4. Strategic outlook
    • 11.14.5. SWOT analysis
  • 11.15. Wedgewood Village Pharmacy, Inc.
    • 11.15.1. Business overview
    • 11.15.2. Financial data
    • 11.15.3. Product landscape
    • 11.15.4. SWOT analysis

Data Tables

  • TABLE 1. Compounding pharmacies industry 360 degree synopsis, 2015 - 2026
  • TABLE 2. Global compounding pharmacies market, 2015 - 2026 (USD Million)
  • TABLE 3. Global compounding pharmacies market, 2020 - 2026 (USD Million)
  • TABLE 4. Global compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 5. Global compounding pharmacies market, by therapeutic area, 2020 - 2026 (USD Million)
  • TABLE 6. Global compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 7. Global compounding pharmacies market, by product, 2020 - 2026 (USD Million)
  • TABLE 8. Global compounding pharmacies market, by application, 2015 - 2026 (USD Million)
  • TABLE 9. Global compounding pharmacies market, by application, 2015 - 2026 (USD Million)
  • TABLE 10. Global compounding pharmacies market, by compounding type, 2013 - 2027 (USD Million)
  • TABLE 11. Global compounding pharmacies market, by compounding type, 2020 - 2026 (USD Million)
  • TABLE 12. Global compounding pharmacies market, by sterility, 2015 - 2026 (USD Million)
  • TABLE 13. Global compounding pharmacies market, by sterility, 2020 - 2026 (USD Million)
  • TABLE 14. Global compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 15. Global compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Million)
  • TABLE 16. Global compounding pharmacies market, by region, 2015 - 2026 (USD Million)
  • TABLE 17. Global compounding pharmacies market, by region, 2020 - 2026 (USD Million)
  • TABLE 18. Industry impact forces
  • TABLE 19. Hormone replacement market, by region, 2015 - 2026, (USD Mn)
  • TABLE 20. Pain management market, by region, 2015 - 2026, (USD Million)
  • TABLE 21. Dermatology market, by region, 2015 - 2026, (USD Million)
  • TABLE 22. Specialty drugs market, by region, 2015 - 2026, (USD Million)
  • TABLE 23. Nutritional supplements market, by region, 2015 - 2026, (USD Million)
  • TABLE 24. Others market, by region, 2015 - 2026, (USD Million)
  • TABLE 25. Oral market by region, 2015 - 2026 (USD Million)
  • TABLE 26. Compounding pharmacies solid preparations market, by region, 2015 - 2026, (USD Mn)
  • TABLE 27. Compounding pharmacies tablets market, by region, 2015 - 2026, (USD Million)
  • TABLE 28. Compounding pharmacies market capsules market, by region, 2015 - 2026, (USD Million)
  • TABLE 29. Compounding pharmacies granules market, by region, 2015 - 2026, (USD Million)
  • TABLE 30. Compounding pharmacies powder market, by region, 2015 - 2026, (USD Million)
  • TABLE 31. Compounding pharmacies others market, by region, 2015 - 2026, (USD Million)
  • TABLE 32. Compounding pharmacies liquid preparations market, by region, 2015 - 2026, (USD Million)
  • TABLE 33. Compounding pharmacies solutions market, by region, 2015 - 2026, (USD Million)
  • TABLE 34. Compounding pharmacies market suspension market, by region, 2015 - 2026, (USD Mn)
  • TABLE 35. Compounding pharmacies emulsion market, by region, 2015 - 2026, (USD Million)
  • TABLE 36. Compounding pharmacies syrup market, by region, 2015 - 2026, (USD Million)
  • TABLE 37. Compounding pharmacies others market, by region, 2015 - 2026, (USD Million)
  • TABLE 38. Topical market, by region, 2015 - 2026, (USD Million)
  • TABLE 39. Compounding pharmacies ointments market, by region, 2015 - 2026, (USD Million)
  • TABLE 40. Compounding pharmacies creams market, by region, 2015 - 2026, (USD Million)
  • TABLE 41. Compounding pharmacies gels market, by region, 2015 - 2026, (USD Million)
  • TABLE 42. Compounding pharmacies pastes market, by region, 2015 - 2026, (USD Million)
  • TABLE 43. Compounding pharmacies others market, 2015 - 2026, (USD Million)
  • TABLE 44. Rectal market by region, 2015 - 2026 (USD Million)
  • TABLE 45. Compounding pharmacies suppositories market, by region, 2015 - 2026, (USD Mn)
  • TABLE 46. Compounding pharmacies enema market, by region, 2015 - 2026, (USD Million)
  • TABLE 47. Compounding pharmacies others market, by region, 2015 - 2026, (USD Million)
  • TABLE 48. Parenteral market by region, 2015 - 2026 (USD Million)
  • TABLE 49. Small volume parenteral (SVP) solutions market by region, 2015 - 2026 (USD Million)
  • TABLE 50. Large volume parenteral (LVP) solutions market by region, 2015 - 2026 (USD Million)
  • TABLE 51. Nasal market by region, 2015 - 2026 (USD Million)
  • TABLE 52. Ophthalmic market by region, 2015 - 2026 (USD Million)
  • TABLE 53. Otic market by region, 2015 - 2026 (USD Million)
  • TABLE 54. Paediatric compounding pharmacies market, by region, 2015 - 2026, (USD Million)
  • TABLE 55. Adult compounding pharmacies market, by region 2015 - 2026, (USD Million)
  • TABLE 56. Geriatric compounding pharmacies market, by region 2015 - 2026, (USD Million)
  • TABLE 57. Veterinary compounding pharmacies market, by region 2015 - 2026, (USD Million)
  • TABLE 58. Pharmaceutical ingredient alteration (PIA) market, by region, 2015 - 2026, (USD Mn)
  • TABLE 59. Currently unavailable pharmaceutical manufacturing (CUPM) market, by region, 2015 - 2026, (USD Million)
  • TABLE 60. Pharmaceutical dosage alteration (PDA) market, by region, 2015 - 2026, (USD Mn)
  • TABLE 61. Others market, by region, 2015 - 2026, (USD Mn)
  • TABLE 62. Sterile compounding pharmacies market, by region, 2015 - 2026, (USD Million)
  • TABLE 63. Non-sterile compounding pharmacies market, by region, 2015 - 2026, (USD Mn)
  • TABLE 64. Hospital pharmacy market, by region, 2015 - 2026, (USD Mn)
  • TABLE 65. Compounding pharmacy market, by region, 2015 - 2026, (USD Mn)
  • TABLE 66. Others market, by region, 2015 - 2026, (USD Million)
  • TABLE 67. North America compounding pharmacies market, by country, 2015 - 2026 (USD Million)
  • TABLE 68. North America compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 69. North America compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 70. North America compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 71. North America compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 72. North America compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 73. North America compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 74. North America compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 75. North America compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 76. North America compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 77. North America compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 78. North America compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 79. North America compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 80. U.S. compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 81. U.S. compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 82. U.S. compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 83. U.S. compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 84. U.S. compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 85. U.S. compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 86. U.S. compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 87. U.S. compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 88. U.S. compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 89. U.S. compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 90. U.S. compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 91. U.S. compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 92. Canada compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 93. Canada compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 94. Canada compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 95. Canada compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 96. Canada compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 97. Canada compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 98. Canada compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 99. Canada compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 100. Canada compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 101. Canada compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 102. Canada compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 103. Canada compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 104. Europe compounding pharmacies market, by country, 2015 - 2026 (USD Million)
  • TABLE 105. Europe compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 106. Europe compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 107. Europe compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 108. Europe compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 109. Europe compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 110. Europe compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 111. Europe compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 112. Europe compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 113. Europe compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 114. Europe compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 115. Europe compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 116. Europe compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 117. Germany compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 118. Germany compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 119. Germany compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 120. Germany compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 121. Germany compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 122. Germany compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 123. Germany compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 124. Germany compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 125. Germany compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 126. Germany compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 127. Germany compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 128. Germany compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 129. UK compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 130. UK compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 131. UK compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 132. UK compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 133. UK compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 134. UK compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 135. UK compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 136. UK compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 137. UK compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 138. UK compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 139. UK compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 140. UK compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 141. Italy compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 142. Italy compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 143. Italy compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 144. Italy compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 145. Italy compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 146. Italy compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 147. Italy compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 148. Italy compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 149. Italy compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 150. Italy compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 151. Italy compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 152. Italy compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 153. Spain compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 154. Spain compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 155. Spain compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 156. Spain compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 157. Spain compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 158. Spain compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 159. Spain compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 160. Spain compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 161. Spain compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 162. Spain compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 163. Spain compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 164. Spain compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 165. France compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 166. France compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 167. France compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 168. France compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 169. France compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 170. France compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 171. France compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 172. France compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 173. France compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 174. France compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 175. France compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 176. France compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 177. Poland compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 178. Poland compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 179. Poland compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 180. Poland compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 181. Poland compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 182. Poland compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 183. Poland compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 184. Poland compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 185. Poland compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 186. Poland compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 187. Poland compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 188. Poland compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 189. Ukraine compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 190. Ukraine compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 191. Ukraine compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 192. Ukraine compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 193. Ukraine compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 194. Ukraine compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 195. Ukraine compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 196. Ukraine compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 197. Ukraine compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 198. Ukraine compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 199. Ukraine compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 200. Ukraine compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 201. Greece compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 202. Greece compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 203. Greece compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 204. Greece compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 205. Greece compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 206. Greece compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 207. Greece compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 208. Greece compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 209. Greece compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 210. Greece compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 211. Greece compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 212. Greece compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 213. Sweden compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 214. Sweden compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 215. Sweden compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 216. Sweden compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 217. Sweden compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 218. Sweden compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 219. Sweden compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 220. Sweden compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 221. Sweden compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 222. Sweden compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 223. Sweden compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 224. Sweden compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 225. Norway compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 226. Norway compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 227. Norway compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 228. Norway compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 229. Norway compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 230. Norway compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 231. Norway compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 232. Norway compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 233. Norway compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 234. Norway compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 235. Norway compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 236. Norway compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 237. Belgium compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 238. Belgium compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 239. Belgium compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 240. Belgium compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 241. Belgium compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 242. Belgium compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 243. Belgium compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 244. Belgium compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 245. Belgium compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 246. Belgium compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 247. Belgium compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 248. Belgium compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 249. Czech Republic compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 250. Czech Republic compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 251. Czech Republic compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 252. Czech Republic compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 253. Czech Republic compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 254. Czech Republic compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 255. Czech Republic compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 256. Czech Republic compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 257. Czech Republic compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 258. Czech Republic compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 259. Czech Republic compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 260. Czech Republic compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 261. Finland compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 262. Finland compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 263. Finland compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 264. Finland compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 265. Finland compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 266. Finland compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 267. Finland compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 268. Finland compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 269. Finland compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 270. Finland compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 271. Finland compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 272. Finland compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 273. Russia compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 274. Russia compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 275. Russia compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 276. Russia compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 277. Russia compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 278. Russia compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 279. Russia compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 280. Russia compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 281. Russia compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 282. Russia compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 283. Russia compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 284. Russia compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 285. Asia Pacific compounding pharmacies market, by country, 2015 - 2026 (USD Million)
  • TABLE 286. Asia Pacific compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 287. Asia Pacific compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 288. Asia Pacific compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 289. Asia Pacific compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 290. Asia Pacific compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 291. Asia Pacific compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 292. Asia Pacific compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 293. Asia Pacific compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 294. Asia Pacific compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 295. Asia Pacific compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 296. Asia Pacific compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 297. Asia Pacific compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 298. China compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 299. China compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 300. China compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 301. China compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 302. China compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 303. China compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 304. China compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 305. China compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 306. China compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 307. China compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 308. China compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 309. China compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 310. India compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 311. India compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 312. India compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 313. India compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 314. India compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 315. India compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 316. India compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 317. India compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 318. India compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 319. India compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 320. India compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 321. India compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 322. Japan compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 323. Japan compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 324. Japan compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 325. Japan compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 326. Japan compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 327. Japan compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 328. Japan compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 329. Japan compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 330. Japan compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 331. Japan compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 332. Japan compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 333. Japan compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 334. Singapore compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 335. Singapore compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 336. Singapore compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 337. Singapore compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 338. Singapore compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 339. Singapore compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 340. Singapore compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 341. Singapore compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 342. Singapore compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 343. Singapore compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 344. Singapore compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 345. Singapore compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 346. Australia compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 347. Australia compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 348. Australia compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 349. Australia compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 350. Australia compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 351. Australia compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 352. Australia compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 353. Australia compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 354. Australia compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 355. Australia compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 356. Australia compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 357. Australia compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 358. Latin America compounding pharmacies market, by country, 2015 - 2026 (USD Million)
  • TABLE 359. Latin America compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 360. Latin America compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 361. Latin America compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 362. Latin America compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 363. Latin America compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 364. Latin America compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 365. Latin America compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 366. Latin America compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 367. Latin America compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 368. Latin America compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 369. Latin America compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 370. Latin America compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 371. Argentina compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 372. Argentina compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 373. Argentina compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 374. Argentina compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 375. Argentina compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 376. Argentina compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 377. Argentina compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 378. Argentina compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 379. Argentina compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 380. Argentina compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 381. Argentina compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 382. Argentina compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 383. Brazil compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 384. Brazil compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 385. Brazil compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 386. Brazil compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 387. Brazil compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 388. Brazil compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 389. Brazil compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 390. Brazil compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 391. Brazil compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 392. Brazil compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 393. Brazil compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 394. Brazil compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 395. Mexico compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 396. Mexico compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 397. Mexico compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 398. Mexico compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 399. Mexico compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 400. Mexico compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 401. Mexico compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 402. Mexico compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 403. Mexico compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 404. Mexico compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 405. Mexico compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 406. Mexico compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 407. Middle East & Africa compounding pharmacies market, by country, 2015 - 2026 (USD Million)
  • TABLE 408. Middle East & Africa compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 409. Middle East & Africa compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 410. Middle East & Africa compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 411. Middle East & Africa compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 412. Middle East & Africa compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 413. Middle East & Africa compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 414. Middle East & Africa compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 415. Middle East & Africa compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 416. Middle East & Africa compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 417. Middle East & Africa compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 418. Middle East & Africa compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 419. Middle East & Africa compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 420. South Africa compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 421. South Africa compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 422. South Africa compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 423. South Africa compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 424. South Africa compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 425. South Africa compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 426. South Africa compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 427. South Africa compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 428. South Africa compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 429. South Africa compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 430. South Africa compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 431. South Africa compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 432. UAE compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 433. UAE compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 434. UAE compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 435. UAE compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 436. UAE compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 437. UAE compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 438. UAE compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 439. UAE compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 440. UAE compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 441. UAE compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 442. UAE compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 443. UAE compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 444. Saudi Arabia compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 445. Saudi Arabia compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 446. Saudi Arabia compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 447. Saudi Arabia compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 448. Saudi Arabia compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 449. Saudi Arabia compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 450. Saudi Arabia compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 451. Saudi Arabia compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 452. Saudi Arabia compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 453. Saudi Arabia compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 454. Saudi Arabia compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 455. Saudi Arabia compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 456. Qatar compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 457. Qatar compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 458. Qatar compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 459. Qatar compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 460. Qatar compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 461. Qatar compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 462. Qatar compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 463. Qatar compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 464. Qatar compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 465. Qatar compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 466. Qatar compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 467. Qatar compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)
  • TABLE 468. Kuwait compounding pharmacies market, by therapeutic area, 2015 - 2026 (USD Million)
  • TABLE 469. Kuwait compounding pharmacies market, by product, 2015 - 2026 (USD Million)
  • TABLE 470. Kuwait compounding pharmacies market, by oral, 2015 - 2026 (USD Million)
  • TABLE 471. Kuwait compounding pharmacies market, by solid preparations, 2015 - 2026 (USD Million)
  • TABLE 472. Kuwait compounding pharmacies market, by liquid preparation, 2015 - 2026 (USD Million)
  • TABLE 473. Kuwait compounding pharmacies market, by topical, 2015 - 2026 (USD Million)
  • TABLE 474. Kuwait compounding pharmacies market, by rectal, 2015 - 2026 (USD Million)
  • TABLE 475. Kuwait compounding pharmacies market, by parenteral, 2015 - 2026 (USD Million)
  • TABLE 476. Kuwait compounding pharmacies market, by application, 2015 - 2026 (USD Mn)
  • TABLE 477. Kuwait compounding pharmacies market, by compounding type, 2015 - 2026 (USD Mn)
  • TABLE 478. Kuwait compounding pharmacies market, by sterility, 2015 - 2026 (USD Mn)
  • TABLE 479. Kuwait compounding pharmacies market, by distribution channel, 2015 - 2026 (USD Mn)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 Global compounding pharmacies market, 2015 - 2026 (USD Million)
  • FIG. 3 Industry ecosystem analysis
  • FIG. 4 Distribution channel analysis
  • FIG. 5 Growth potential analysis, by therapeutic area
  • FIG. 6 Growth potential analysis, by product
  • FIG. 7 Growth potential analysis, by application
  • FIG. 8 Growth potential analysis, by compounding type
  • FIG. 9 Growth potential analysis, by sterility
  • FIG. 10 Growth potential analysis, by distribution channel
  • FIG. 11 Porter's Analysis
  • FIG. 12 PESTEL Analysis
  • FIG. 13 Key segment trends
  • FIG. 14 Key segment trends
  • FIG. 15 Key segment trends
  • FIG. 16 Key segment trends
  • FIG. 17 Key segment trends
  • FIG. 18 Key segment trends
  • FIG. 19 Key regional trends
  • FIG. 20 Strategy Dashboard